| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |